Assessing the Accuracy of Dual Energy CT as a Method for Identifying Renal Damage

Overview

About this study

The purpose of this study is to see how the contrast affects your kidney function. Your kidney function will be measured by testing several blood and urine samples that you provide before and after the CT scan or arterial interventional procedure. A CT scan of your kidneys will also be performed after the CT scan or arterial interventional procedure.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Patients will be included if they have

Ordered contrast-enhanced CT or contrast-enhanced arterial interventional procedure, to be obtained for usual clinical care.

Exclusion Criteria

Pre-existing renal dialysis requirements or
Receiving iodinated contrast from a separate imaging procedure within 7 days before the CT scan, as this exposure may independently affect biomarker results.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator David Kallmes, M.D.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

David Kallmes, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials